Skip to navigation Skip to main content Skip to footer

Approved research

Frequency, phenotypic spectrum, and penetrance of pathogenic variation in cancer susceptibility genes in the general population

Principal Investigator: Dr Douglas Stewart
Approved Research ID: 54389
Approval date: June 9th 2020

Lay summary

In our study, we will investigate genes that increase risk for cancer. To do this, we will count the number of mutations in genes known (or suspected) to increase the risk of cancer in the UK Biobank dataset. We will do this using well-established genetic and epidemiologic methods. Our group has many years of experience of doing this type of analysis, although in smaller datasets. Once we identify participants with mutations in the UK Biobank dataset, we will study the medical problems, especially cancer, that may arise with that damaging variation. Since cancer-associated genes may also cause problems in human development, we will examine medical problems affecting learning, the heart, and growth, among others. We will compare the frequency of these problems in people with mutations ("cases") to those without mutations ("controls"). We will use statistics whenever possible to be certain of our observations. We will first focus on genes that are well known to increase the risk for cancer. We will also study genes that are suspected to cause cancer. In this way, new cancer-associated genes may be discovered. By studying non-cancer medical problems (such as heart defects, or growth issues), we may identify new ways for doctors to diagnosis disease. We expect our analysis of the first 50,000 exomes will take two years; additional releases of UK Biobank data will take additional time. Findings from our study may benefit public health from 1) more accurate counts of cancer-associated mutations in the population, 2) better understanding of how often those mutations cause cancer, 3) better understanding of how often those mutations cause other medical problems, 4) description of new rare diseases.